However, this study provides the foundation to support potential therapeutic trials examining specific agents with MMP inhibitory activities (such as doxycyline) as modulators of excessive MMP-8 and/or MMP-9 activity in children with ARDS. The gene discussed is MMP8; the disease is acute respiratory distress syndrome.